Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Medical Officer sold 1,521 shares at $30.88 ($46,968)
  2. 4 Open-market sale COFO and Secretary sold 1,521 shares at $30.89 ($46,984)
  3. 4 Open-market sale Director sold 1,377 shares at $30.88 ($42,522)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Open-market sale COFO and Secretary sold 10,000 shares at an average $29.53 ($295,339)
  9. 4 Open-market sale Chief Medical Officer sold 1,459 shares at $28.48 ($41,552)
  10. 4 Open-market sale Chief Medical Officer sold 4,087 shares at an average $28.52 ($116,568)
  11. 4 Open-market sale Director sold 2,970 shares at $28.44 ($84,467)
  12. 4 Open-market sale COFO and Secretary sold 2,636 shares at $28.44 ($74,968)
  13. 4 Open-market sale President and CEO sold 4,800 shares at $28.44 ($136,512)
  14. 4/A Open-market sale COFO and Secretary sold 2,912 shares at $28.70 ($83,574)
  15. 8-K Event Regulation FD disclosure
  16. 4 Open-market sale Chief Medical Officer sold 2,913 shares at $28.69 ($83,574)
  17. 4 Open-market sale COFO and Secretary sold 2,912 shares at $28.70 ($83,574)
  18. 4 Open-market sale President and CEO sold 5,029 shares at $28.73 ($144,483)
  19. 4 Open-market sale Director sold 20,000 shares at $30.48 ($609,600)
  20. 4 Open-market sale Director sold 20,000 shares at an average $30.27 ($605,463)

Page 17 of 40 · 789 filings